Ninepoint Partners LP Invests $720,000 in Zoetis Inc. (NYSE:ZTS)

Ninepoint Partners LP purchased a new position in shares of Zoetis Inc. (NYSE:ZTS) during the fourth quarter, HoldingsChannel reports. The firm purchased 3,650 shares of the company’s stock, valued at approximately $720,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Blue Bell Private Wealth Management LLC increased its stake in shares of Zoetis by 222.5% during the fourth quarter. Blue Bell Private Wealth Management LLC now owns 129 shares of the company’s stock worth $25,000 after acquiring an additional 89 shares during the period. Nelson Van Denburg & Campbell Wealth Management Group LLC boosted its holdings in Zoetis by 430.8% during the first quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 138 shares of the company’s stock worth $26,000 after buying an additional 112 shares in the last quarter. VitalStone Financial LLC purchased a new stake in Zoetis during the first quarter worth about $37,000. Evermay Wealth Management LLC boosted its holdings in Zoetis by 439.3% during the first quarter. Evermay Wealth Management LLC now owns 151 shares of the company’s stock worth $25,000 after buying an additional 123 shares in the last quarter. Finally, Worth Asset Management LLC purchased a new stake in Zoetis during the first quarter worth about $26,000. 92.80% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

ZTS has been the topic of a number of research analyst reports. The Goldman Sachs Group boosted their price objective on shares of Zoetis from $190.00 to $226.00 and gave the stock a “buy” rating in a report on Wednesday, January 17th. Barclays upped their price target on shares of Zoetis from $255.00 to $260.00 and gave the company an “overweight” rating in a report on Wednesday, February 14th. Stifel Nicolaus reduced their price target on shares of Zoetis from $215.00 to $195.00 and set a “buy” rating on the stock in a report on Tuesday, April 2nd. StockNews.com downgraded shares of Zoetis from a “strong-buy” rating to a “buy” rating in a report on Tuesday, February 20th. Finally, Piper Sandler reissued an “overweight” rating and set a $195.00 price objective (down previously from $220.00) on shares of Zoetis in a research note on Tuesday. Eight equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company currently has an average rating of “Buy” and a consensus target price of $221.75.

Zoetis Trading Down 3.5 %

Shares of Zoetis stock traded down $5.31 during trading hours on Friday, hitting $147.80. The company’s stock had a trading volume of 3,162,858 shares, compared to its average volume of 2,990,773. Zoetis Inc. has a 1-year low of $147.11 and a 1-year high of $201.92. The business has a fifty day moving average of $176.49 and a 200 day moving average of $180.20. The company has a market capitalization of $67.60 billion, a PE ratio of 29.32, a P/E/G ratio of 2.32 and a beta of 0.85. The company has a quick ratio of 2.00, a current ratio of 3.36 and a debt-to-equity ratio of 1.32.

Zoetis (NYSE:ZTS) last released its quarterly earnings data on Tuesday, February 13th. The company reported $1.24 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.32 by ($0.08). Zoetis had a return on equity of 51.25% and a net margin of 27.43%. The business had revenue of $2.21 billion during the quarter, compared to analyst estimates of $2.19 billion. During the same period in the previous year, the company earned $1.15 EPS. Zoetis’s revenue was up 8.5% on a year-over-year basis. As a group, equities analysts forecast that Zoetis Inc. will post 5.79 EPS for the current year.

Zoetis Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 4th. Stockholders of record on Friday, April 19th will be paid a $0.432 dividend. The ex-dividend date is Thursday, April 18th. This represents a $1.73 annualized dividend and a dividend yield of 1.17%. Zoetis’s dividend payout ratio (DPR) is presently 34.12%.

Insider Activity

In other news, EVP Roxanne Lagano sold 923 shares of the company’s stock in a transaction on Thursday, April 18th. The shares were sold at an average price of $151.17, for a total value of $139,529.91. Following the completion of the transaction, the executive vice president now directly owns 14,800 shares in the company, valued at $2,237,316. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Over the last three months, insiders sold 2,209 shares of company stock worth $371,293. 0.12% of the stock is currently owned by company insiders.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.